Merck KGaA, Darmstadt, Allemagne, annonce le premier patient traité dans l'essai de phase 3 d'un conjugué anticorps-médicament expérimental dans le cancer colorectal

Merck KGaA, Darmstadt, Allemagne, entreprise de sciences et technologies, a annoncé l'administration de la première dose au premier patient de l'essai de phase 3 PROCEADE-CRC-03. Cette ...
The Conversation

Cancer colorectal : qui doit se faire dépister, et comment ?

S’il est traité suffisamment tôt, le cancer colorectal guérit dans 9 cas sur 10. Malheureusement, en France, son dépistage est à la peine, loin en deçà du seuil recommandé au niveau européen. Comment ...
Live Science

More young people are getting colorectal cancer — here's what scientists think might be happening

People 65 and older are seeing their rates of colorectal cancer drop, but younger people are being felled by a rising number ...
Investing.com France

Exelixis s’associe à Merck pour un essai sur le cancer colorectal

ALAMEDA, Californie - Exelixis Inc. (NASDAQ:EXEL) a annoncé aujourd’hui une collaboration de développement clinique avec Merck pour fournir KEYTRUDA QLEX dans le cadre d’un essai de phase 3 prévu chez ...
Medscape

Colorectal Cancer Predicted to Keep Rising in Younger Adults

CHICAGO — Colorectal malignancy rates, particularly for rectal cancer, are accelerating among Americans younger than 45, and unless something changes, the rate is predicted to continue increasing out ...
Healthline

Screening Guidelines for Colorectal Cancer

Colorectal cancer screening can help your doctor find and remove precancerous polyps before they become cancer or find colorectal cancer early when it’s most treatable. Colorectal cancer screening ...
Everyday Health

What Is Early-Onset Colorectal Cancer?

While colorectal cancer mostly occurs among people age 50 and older, the number of younger people getting the illness has dramatically climbed over the past few decades. Because young people don’t ...